Transaction DateRecipientSharesTypePriceValue
13th October 2020Investment Company, Inc. Awm30,987Open or private sale$6.59$204,226.02
12th October 2020Investment Company, Inc. Awm14,013Open or private sale$6.52$91,300.30
9th October 2020Investment Company, Inc. Awm5,000Open or private sale$6.45$32,250.00
5th October 2020Investment Company, Inc. Awm2,275Open or private sale$6.40$14,560.00
29th September 2020Investment Company, Inc. Awm29,000Open or private sale$6.13$177,912.10
28th September 2020Investment Company, Inc. Awm21,000Open or private sale$6.08$127,755.60
28th September 2020Investment Company, Inc. Awm25,000Open or private sale$6.13$153,330.00
2nd September 2020Douglas P Baker10,000Open or private sale$20.00$200,000.00
2nd September 2020Douglas P Baker10,000Exercise of derivative$2.46$24,600.00
25th August 2020Investment Company, Inc. Awm100Open or private sale$5.00$500.00
Optimize Rx
Optimize Rx logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985.

Ticker: OPRX
Sector: Technology Services
Industry: Data Processing Services
SEC Central Index Key (CIK): 1448431
Employees: 50
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags